Lawrence Erik Kurzius
Chairman, President & CEO at McCormick & Company Incorporated
Sits on 3 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Elanco Animal Health Incorporated, 3 years.
Elanco Animal Health Incorporated
Director
McCormick & Company Incorporated
Director · Chairman & CEO
The Cooper Companies Inc.
Director
Chief executive roles
McCormick & Company Incorporated
· Chairman, President & CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 15, 2025 | McCormick & Company Incorporated | Option exercise | +1,734 | — | — |
| Mar 14, 2025 | McCormick & Company Incorporated | Shares withheld for tax | −642 | $80.18 | $51,476 |
| Mar 11, 2025 | Elanco Animal Health Incorporated | Open-market purchase | +10,000 | $10.20 | $102,000 |
| Mar 7, 2025 | Elanco Animal Health Incorporated | Open-market purchase | +10,000 | $10.90 | $109,000 |
| Feb 18, 2025 | McCormick & Company Incorporated | Shares withheld for tax | −30,550 | $76.96 | $2,351,128 |
| Feb 3, 2025 | McCormick & Company Incorporated | Option exercise | +50,000 | $49.96 | $2,498,000 |
| Feb 3, 2025 | McCormick & Company Incorporated | Open-market sale | −50,000 | $76.81 | $3,840,500 |
| Jan 27, 2025 | McCormick & Company Incorporated | Grant or award | +77,637 | — | — |
| Nov 29, 2024 | Elanco Animal Health Incorporated | Grant or award | +18,169 | — | — |
| Sep 11, 2024 | McCormick & Company Incorporated | Gift | −1 | — | — |
| Sep 11, 2024 | McCormick & Company Incorporated | Gift | −1 | — | — |
| Jul 17, 2024 | McCormick & Company Incorporated | Open-market sale | −25,000 | $75.00 | $1,875,000 |
| Jul 10, 2024 | McCormick & Company Incorporated | Other | −25,000 | — | — |
| Jul 10, 2024 | McCormick & Company Incorporated | Other | +25,000 | — | — |
| May 21, 2024 | McCormick & Company Incorporated | Option exercise | +80,000 | $38.15 | $3,052,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.